Insider Trading July 9, 2026 05:15 PM

Verisign Executive Divests $67,307 in Common Shares Amid Strong Q1 Performance

Thomas Indelicarto's recent stock sale occurs as the domain registry leader reports earnings that beat analyst estimates, though valuation metrics suggest potential headwinds.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
VRSN

Thomas C. Indelicarto, serving as Executive Vice President, General Counsel, and Secretary at Verisign Inc. (NASDAQ:VRSN), executed a sale of company equity on July 8, 2026. This transaction involved the disposal of 250 shares of Verisign common stock at a price point of $269.23 per share, resulting in total proceeds of $67,307. Post-transaction, Indelicarto retains a direct holding of 36,051.0439 shares of Verisign common stock. The transaction occurs while Verisign trades at $269.98, reflecting a market capitalization of $24.6 billion. Independent analysis indicates the stock may be overvalued relative to its fair value, placing it on lists of overvalued companies. The company demonstrates an impressive gross profit margin of 88%, with upcoming earnings scheduled for release on July 23, 2026.

Verisign Executive Divests $67,307 in Common Shares Amid Strong Q1 Performance
VRSN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Verisign executive Thomas Indelicarto sold 250 shares at $269.23 per share, totaling $67,307, while retaining over 36,000 shares.
  • The company reported Q1 2026 earnings that beat expectations, with EPS of $2.34 and revenue of $429 million.
  • Despite strong financials, the stock is flagged as overvalued relative to fair value by InvestingPro analysis.

Executive Divestment and Shareholding Structure

Thomas C. Indelicarto, who holds the positions of Executive Vice President, General Counsel, and Secretary at Verisign Inc., reported a transaction involving the sale of company equity on July 8, 2026. The executed sale consisted of 250 shares of Verisign common stock. These shares were disposed of at a price of $269.23 per share. The total value derived from this transaction was $67,307. Following the completion of this sale, Mr. Indelicarto's direct holdings in Verisign common stock stand at 36,051.0439 shares.

Market Valuation and Financial Metrics

The transaction occurs while Verisign is trading at a price of $269.98 per share. The company's market capitalization stands at $24.6 billion. According to analysis provided by InvestingPro, the stock appears to be overvalued relative to its fair value. This assessment places Verisign among companies categorized on the Most Overvalued list. Despite the valuation concerns, the company maintains a gross profit margin of 88%. Verisign has earnings scheduled for release on July 23, 2026.

Recent Earnings Performance and Analyst Reaction

Verisign Inc. recently reported its first-quarter earnings for 2026. The results surpassed analysts' expectations. The company achieved an earnings per share (EPS) of $2.34. This figure is slightly above the forecasted EPS of $2.31. Verisign's revenue for the quarter reached $429 million. This revenue figure exceeded the projected amount of $425.16 million. These results indicate a strong financial performance for the company. Following the earnings announcement, analysts noted a positive reaction from investors. The company's ability to exceed both earnings and revenue projections highlights its operational efficiency. Investors and analysts are closely monitoring these developments as they assess Verisign's future prospects.

Investment Analysis and Strategic Context

InvestingPro offers 8 additional exclusive tips and comprehensive Pro Research Reports for deeper analysis. ProPicks AI evaluates VRSN every month against thousands of alternatives using 100+ financial metrics. The analysis found Siemens Energy (+231.5%) and Sandisk (+189%) before the crowd did. The evaluation asks whether VRSN could be the next opportunity or if there is a better opportunity in the same space. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Risks

  • The stock is identified as overvalued relative to its fair value, suggesting potential downside risk for investors.
  • The company faces upcoming earnings release on July 23, 2026, which could trigger volatility if expectations are not met.
  • Analyst reactions to the Q1 results were positive, but future prospects remain under close monitoring, indicating uncertainty in sustained growth.

More from Insider Trading

Samsara's CTO Executes Multi-Million Dollar Share Divestment Under Pre-Planned Trading Schedule Jul 9, 2026 Concentrix CEO Purchases Shares Amid Earnings Miss and Downgraded Outlook Jul 9, 2026 IONIS Pharmaceuticals Director Allene Diaz Offloads Shares Under Pre-Arranged Plan Jul 9, 2026 Ionis Pharmaceuticals Executive Divests Position Amid Clinical Setback; Share Price Under Pressure Jul 9, 2026 Guidewire Software Executive Sells Shares Under Pre-Arranged Plan Amid Mixed Financial Results Jul 9, 2026